Beyond HRD status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer.
Kjeldsen MK, Jørgensen M, Grønseth DSB, Schønemann-Lund M, Nyvang GB, Haslund CA, Knudsen AO, Motavaf AK, Malander S, Anttila M, Lindahl G, Mäenpää J, Dimoula M, Werner TL, Iversen TZ, Hietanen S, Fokdal L, Dahlstrand H, Bjorge L, Birrer MJ, Mirza MR, Rossing M.
Kjeldsen MK, et al. Among authors: knudsen ao.
Cancer Res Commun. 2024 Nov 26. doi: 10.1158/2767-9764.CRC-24-0294. Online ahead of print.
Cancer Res Commun. 2024.
PMID: 39591206
Free article.